About Us
DiaUnion is a center of excellence in research into type 1 diabetes and related autoimmune diseases
DiaUnion 2.0 was launched in July 2024 with the ambition to develop a model for establishing permanent screening programs for type 1 diabetes (T1D) and the related autoimmune diseases, celiac disease and autoimmune thyroid disease.
DiaUnion has created a cross-border Center of Excellence in Medicon Valley and is until 2027 scaling up its program targeting to screen 45,000 people in Denmark and southern Sweden.
In Medicon Valley, the Danish/Swedish life-science cluster in the Øresund region, there are strong and internationally recognized competencies within screening, genetics and immunology in T1D as well as related autoimmune diseases. DiaUnion 1.0 was created in 2020 to bring these competencies together and to contribute to reducing the burden on patients and the cost to society.
DiaUnion 1.0 was supported by EU-Interreg ÖKS and DiaUnion 2.0 is supported by an unrestricted research grant of €3.9MM from Sanofi.
View press releases from the DiaUnion 2.0 launch in Swedish and Danish HERE
Screening Centers
Lund University Clinical Research Center Malmø (CRC)
- Daniel Agardh, Principal Investigator, Adjunct Professor, MD
- Åke Lernmark, Co-Investigator, Senior Professor
- Markus Lundgren, Co-Investigator, Chief Physician, DMSc
- Johan Svensson, Co-Investigator, Chief Physician, DMSc
- Alexander Lind, Postdoc, PhD
- Maria Scherman, MD, PhD Student
- Flemming Pociot, Principal Investigator, Professor, Research Leader, DMSc
- Jesper Johannesen, Co-Investigator, Professor, Chief Physician, DMSc
- Julie Christine Antvorskov, Assistant professor, PhD
- Julie Hviid Klæbel, Postdoc, PhD
Administration
Medicon Valley Alliance (MVA)
- Finn Stensbjerg Kristensen, Program Director, DiaUnion, B.Sc., MBA
- Mette Bach Dyremose, Head of Communication, DiaUnion/ReproUnion, MVA, MBA
